molecular imaging, radiotherapy, oncology- ucl- lab'insight biomedical imaging

1

Prof. Vincent Grégoire Director

Prof. John A. Lee Researcher

Lab’Insight event – Gosselies, October 25th, 2011

Expertise • Molecular imaging for oncology (PET, SPECT/CT, AR) • Radiation oncology (preclinical and clinical research) • Radiobiology • Radiochemistry (GMP radiotracers) • Medical physics • Medical imaging and image processing (partnership with UCL/ICTEAM)

For companies active in : • Cancer therapy • Nuclear medicine • Pharmaceutics

2

EXPERTISE IN BIOMEDICAL IMAGING AND TARGETED COMPANIES

3

→ Production of certified tracers for PET and SPECT (FDG, FAZA, EF3, FLT, FMISO, choline, acetate, methionine, O15, N13, Y89, Zr89)

→ Expertise in the biological effects and radiobiological calibration of non conventional radiation beam

→ Tools for target delineation on PET images → Commissioning of radiotherapy devices → Modeling of linear accelerators and radiation therapy devices

(dosimetry and Monte Carlo simulations, photons/protons/hadrons)

Example:

&

Services Provided to Companies

4

Complete molecular imaging platform + tracer production facility

Special Equipments

5 5

patient treatment 5-7 weeks, daily

tumour control / toxicity

treatment safety

quality assurance

dosimetry

tumour targeting

tumour radiosensitivity

tumour biology

tracer synthesis

tumour imaging

tumour motion

tumour evolution

international guidelines

HPV tumor micro- environment

EF3, FAZA, FLT, FMISO, acetate,

methionine, O15, N13, Y89, Zr89

non-rigid registration

adaptive treatment

Research Projects

6

CONTACT

Prof. Vincent Grégoire Director

Vincent.Gregoire@uclouvain.be - Phone : +32(0)2 764 9443

UCLouvain/IREC Molecular imaging, radiotherapy, and oncology Avenue Hippocrate 55 bte B1.54.07, 1200 Bruxelles